Esperion Therapeutics, Inc. — Director's Dealing 2014

Oct 21, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Esperion Therapeutics, Inc. (ESPR)
CIK: 0001434868
Period of Report: 2014-10-21

Reporting Person: DOMAIN PARTERS VII L P (10% Owner)
Reporting Person: BLAIR JAMES C (10% Owner)
Reporting Person: DOVEY BRIAN H (10% Owner)
Reporting Person: TREU JESSE I (10% Owner)
Reporting Person: SCHOEMAKER KATHLEEN K (10% Owner)
Reporting Person: VITULLO NICOLE (Director, 10% Owner)
Reporting Person: Halak Brian K (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-10-21	Common Stock	P	500000	$20.00	Acquired	2566935	Direct

Footnotes

F1: The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her.

F2: As managing members of the sole general partner of DP VII Associates, L.P., each Reporting Owner listed below may also be deemed to indirectly beneficially own 35,253 shares of Common Stock held by DP VII Associates, L.P.

F3: As managing members of Domain Associates, LLC, each Reporting Owner listed below may also be deemed to indirectly beneficially own 21,471 shares of Common Stock held by Domain Associates, LLC.